CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- 8-K Event Results of operations
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Executive or director change
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 8-K Event Material agreement
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Exit or restructuring costs · Change in control · Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Results of operations · Regulation FD disclosure · Other events
Page 1 of 4 · 77 filings